Unjoni Ewropea - Latvjan - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - tenecteplase - miokarda infarkts - antitrombotiskie līdzekļi - metalyse indicēts thrombolytic attieksmi pret iespējamo miokarda infarkts ar noturīgiem st pacēlums vai nesen kreisais saišķis filiāle bloku sešu stundu laikā pēc akūta miokarda infarkta pazīmju parādīšanos.

Latvja - Latvjan - Zāļu valsts aģentūra

desma gmbh, germany - biperidēna hidrohlorīds - tablete - 2 mg

Unjoni Ewropea - Latvjan - EMA (European Medicines Agency)

paion deutschland gmbh - angiotensīna ii acetāts - hypotension; shock - agents, kas iedarbojas uz renīna-angiotenzīna sistēmu - giapreza ir indicēts, lai ārstētu ugunsizturīgo hipotensija pieaugušajiem ar septisko vai citu sadales šoks, kas paliek hypotensive neskatoties uz atbilstoša apjoma atgūšanas un piemērošanu, kateholamīnu, un citus pieejamus vasopressor terapiju.

Unjoni Ewropea - Latvjan - EMA (European Medicines Agency)

janssen-cilag international nv - bedaquilīna fumarāts - tuberkuloze, pret multidrugiem izturīga - antimikobaktērijas - sirturo ir norādīts, izmantot atbilstošu kombināciju režīms, lai plaušu tām rezistentas tuberkulozes (mdr-tb) pieaugušo un pusaudžu pacientiem (12 gadi, lai mazāks par 18 gadiem un kas sver vismaz 30 kg), kad efektīvu ārstēšanas shēmu citādi nevar sastāv iemesli, pretestības vai panesamības. jāņem vērā oficiālās vadlīnijas par piemērotu izmantot antibakteriālas vielas.

Latvja - Latvjan - Zāļu valsts aģentūra

desma gmbh, germany - biperidēna laktāts - Šķīdums injekcijām - 5 mg/ml

Unjoni Ewropea - Latvjan - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - doksorubicīna hidrohlorīds - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiski līdzekļi - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Unjoni Ewropea - Latvjan - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanīds - tuberkuloze, pret multidrugiem izturīga - antimikobaktērijas - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 un 5. jāņem vērā oficiālās vadlīnijas par piemērotu izmantot antibakteriālas vielas.

Unjoni Ewropea - Latvjan - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiski līdzekļi - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Unjoni Ewropea - Latvjan - EMA (European Medicines Agency)

elanco gmbh - monenzīns (monenzīna nātrija sāls) - narkotiku profilaksei un/vai ārstēšanai acetonemia - liellopi (govis un teļi) - lai samazinātu ketozes sastopamību peritropieliskajā piena govs / telē, no kuras sagaidāms ketoze.

Unjoni Ewropea - Latvjan - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ombitasvir, paritaprevir, ritonavir - c hepatīts, hronisks - pretvīrusu līdzekļi sistēmiskai lietošanai - viekirax ir minēta kopā ar citām zālēm, ārstēšanai hronisku c hepatītu (chc) pieaugušajiem. hepatīta c vīrusa (hcv) genotipa specifiska aktivitāte.